Cribstone Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30
Closed -$3K 470
2022
Q3
$3K Hold
30
﹤0.01% 332
2022
Q2
$3K Hold
30
﹤0.01% 335
2022
Q1
$4K Sell
30
-1
-3% -$121 ﹤0.01% 331
2021
Q4
$4K Hold
31
﹤0.01% 332
2021
Q3
$4K Hold
31
﹤0.01% 311
2021
Q2
$5K Hold
31
﹤0.01% 302
2021
Q1
$5K Hold
31
﹤0.01% 288
2020
Q4
$5K Hold
31
﹤0.01% 280
2020
Q3
$4K Sell
31
-28
-47% -$3.66K ﹤0.01% 242
2020
Q2
$7K Sell
59
-41
-41% -$4.72K 0.01% 247
2020
Q1
$10K Hold
100
0.01% 213
2019
Q4
$15K Sell
100
-2
-2% -$276 0.01% 234
2019
Q3
$14K Sell
102
-103
-50% -$13.3K 0.01% 387
2019
Q2
$23K Sell
205
-77
-27% -$9.02K 0.01% 336
2019
Q1
$35K Buy
282
+2
+0.7% +$227 0.02% 290
2018
Q4
$28K Buy
280
+103
+58% +$11.6K 0.01% 328
2018
Q3
$23K Sell
177
-21
-11% -$2.5K 0.01% 385
2018
Q2
$21K Hold
198
0.01% 393
2018
Q1
$21K Hold
198
0.01% 381
2017
Q4
$23K Hold
198
0.01% 433
2017
Q3
$23K Hold
198
0.01% 377
2017
Q2
$25K Hold
198
0.01% 362
2017
Q1
$23K Hold
198
0.01% 404
2016
Q4
$22K Hold
198
0.01% 383
2016
Q3
$24K Hold
198
0.01% 381
2016
Q2
$23K Buy
+198
New +$22.4K 0.01% 400

Other funds holding ZBH

Cribstone Capital Management's ZBH Position: Q4 2022 in Review

Cribstone Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 30 shares — an estimated $3K sold.

Cribstone Capital Management first reported a position in ZBH in Q2 2016 and held it in 26 quarters. The position peaked at $35K in Q1 2019. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Cribstone Capital Management reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
  • Cribstone Capital Management sold 30 Zimmer Biomet shares in Q4 2022, an estimated $3K.
  • Cribstone Capital Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 26 quarters.
  • Cribstone Capital Management's Zimmer Biomet position peaked at $35K in Q1 2019.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.